OptimizeRx (OPRX) Cash & Equivalents Growth (5y) (2015 - 2026)
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Veeva Systems | 30.85 Bn | 24.28 Bn | 622.47 Mn |
| 2 | BrightSpring Health Services | 12.29 Bn | 11.41 Bn | 482.22 Mn |
| 3 | Healthequity | 7.80 Bn | 7.48 Bn | 256.31 Mn |
| 4 | Hinge Health | 4.82 Bn | 4.51 Bn | 154.23 Mn |
| 5 | Doximity | 4.21 Bn | 3.46 Bn | 125.97 Mn |
| 6 | Waystar Holding | 4.18 Bn | 4.03 Bn | 268.04 Mn |
| 7 | 10x Genomics | 3.78 Bn | 3.24 Bn | 106.18 Mn |
| 8 | Privia Health | 2.65 Bn | 2.28 Bn | 595.71 Mn |
| 9 | Omnicell | 1.95 Bn | 1.78 Bn | 140.36 Mn |
| 10 | OptimizeRx | 101.31 Mn | 81.14 Mn | 15.12 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -24.51% |
| Dec 31, 2025 | 17.31% |
| Sep 30, 2025 | 10.16% |
| Jun 30, 2025 | 3.28% |
| Mar 31, 2025 | 1.73% |
| Dec 31, 2024 | -6.63% |
| Sep 30, 2024 | -11.53% |
| Jun 30, 2024 | -13.30% |
| Mar 31, 2024 | 8.41% |
| Dec 31, 2023 | 9.22% |
| Sep 30, 2023 | -6.01% |
| Jun 30, 2023 | -3.96% |
| Mar 31, 2023 | 30.77% |
| Dec 31, 2022 | 28.87% |
| Sep 30, 2022 | 52.49% |
| Jun 30, 2022 | 71.78% |
| Mar 31, 2022 | 67.63% |
| Dec 31, 2021 | 64.48% |
| Sep 30, 2021 | 62.21% |
| Jun 30, 2021 | 61.81% |
| Mar 31, 2021 | 61.25% |
| Dec 31, 2020 | 5.08% |
| Sep 30, 2020 | 8.04% |
| Jun 30, 2020 | 31.09% |
| Mar 31, 2020 | 34.07% |
| Dec 31, 2019 | 40.47% |
| Sep 30, 2019 | 55.63% |
| Jun 30, 2019 | 53.79% |
| Mar 31, 2019 | 20.25% |
| Dec 31, 2018 | 51.46% |
| Sep 30, 2018 | 94.43% |
| Jun 30, 2018 | 102.51% |
| Mar 31, 2018 | 75.20% |
| Dec 31, 2017 | 78.30% |
| Sep 30, 2017 | 77.74% |
| Jun 30, 2017 | 61.76% |
| Mar 31, 2017 | 53.16% |
| Dec 31, 2016 | 48.96% |
| Sep 30, 2016 | 49.35% |
| Jun 30, 2016 | 50.82% |
| Dec 31, 2015 | 45.05% |